Abnormal lower motor neuron morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal ocular motility
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal upper motor neuron morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the ankles
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Abnormality of the bladder
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the corticospinal tract
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the eye
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Alzheimer's Disease
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
In contrast, expression of alsin did not suppress neurotoxicity by other neurodegenerative insults such as Alzheimer's disease-related genes.
|
14970233 |
2004 |
Alzheimer's Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
Following rigorous selection, the circRNA-associated ceRNA networks in this AD mouse model were discovered to be mainly involved in dendritic development and memory (Sorbs2) and mouse neural development (ALS2).
|
31786335 |
2019 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In the present study, we sought to understand whether alsin, which is mutated in an inherited juvenile form of ALS, functionally converges on Rac1-dependent pathways acted upon by SOD1(G93A) to regulate Nox-dependent ROS production.
|
21937428 |
2011 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Mutations of ALS2 are not a common cause of ALS.
|
14676054 |
2003 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Mutation of the ALS2 gene encoding alsin is linked to the onset of autosomal recessive motor neuron diseases, including juvenile-onset amyotrophic lateral sclerosis (ALS).
|
14970233 |
2004 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
One form of juvenile onset autosomal recessive ALS (ALS2) has been linked to the loss of function of the ALS2 gene.
|
17093100 |
2006 |
Amyotrophic Lateral Sclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Direct sequencing analyses were performed in 19 genes, including ALS/frontotemporal lobar degeneration (FTLD)-related genes (SOD2, SOD3, ALS2/alsin, SMN1, PGRN, ANG, VEGF, VCP, VAPB, DCTN1, CHMP2B, and TARDBP or TDP-43), tauopathy-related gene (GSK3beta), and parkinsonism-related genes (alpha-synuclein, LRRK2, parkin, DJ-1, PINK1, and ATP13A2).
|
18759352 |
2008 |
Amyotrophic Lateral Sclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Alsin, the product of the recently cloned ALS-causative gene, the ALS2 gene, is linked to a Rac1/phosphatidylinositol-3 kinase/Akt3 pathway that specifically suppresses motoneuronal death induced by FSOD1.
|
16909018 |
2005 |
Amyotrophic Lateral Sclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
The combined evidence from mice and humans shows that deficiency in ALS2 causes an upper motor neuron disease that in humans closely resembles a severe form of hereditary spastic paralysis, and that is quite distinct from amyotrophic lateral sclerosis.
|
16802286 |
2006 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Amyotrophic lateral sclerosis 2 (ALS2) is an autosomal recessive form of juvenile ALS and has been mapped to human chromosome 2q33.
|
11586298 |
2001 |
Amyotrophic Lateral Sclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
ALS animal models in this review include strains of rodents that are transgenic for superoxide dismutase 1 (SOD1), ALS2 knockout mice, and mice that are transgenic for cytoskeletal abnormalities.
|
18026741 |
2008 |
Amyotrophic Lateral Sclerosis
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|
Amyotrophic Lateral Sclerosis
|
0.200 |
Biomarker
|
disease |
LHGDN |
ALS2CL, the novel protein highly homologous to the carboxy-terminal half of ALS2, binds to Rab5 and modulates endosome dynamics.
|
15388334 |
2004 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
To examine whether ALS2 is mutated in Japanese ALS patients sharing some characteristics of ALS2, we analyzed ALS2 gene from three patients with AR-ALS.
|
12866199 |
2003 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
LHGDN |
Alsin and the molecular pathways of amyotrophic lateral sclerosis.
|
17955197 |
2007 |
Amyotrophic Lateral Sclerosis
|
0.200 |
Biomarker
|
disease |
LHGDN |
[Causative genes for familial amyotrophic lateral sclerosis].
|
12138710 |
2002 |
Amyotrophic Lateral Sclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
|
27439389 |
2016 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Recently, the generation of new animal models of ALS has been made possible with the discovery of ALS-linked mutations in other genes encoding for alsin, dynactin, senataxin, VAPB, TDP-43 and FUS.
|
20728492 |
2011 |